Elysium Health expands into peptides as HHS eases compounding rules
Elysium Health, the New York-based longevity company best known for its NAD+-boosting supplement Basis, has announced its move into
DO
By Daniel Okafor · Regulatory Correspondent
Nov 6 10:50 ETSource: Nutraceutical Business Review
From the source
Read at nutraceuticalbusinessreview.comElysium Health expands into peptides as HHS eases compounding rules
Elysium Health, the New York-based longevity company best known for its NAD+-boosting supplement Basis, has announced its move into peptides.
